HCA Healthcare, Inc. (FRA:2BH)
Germany
· Delayed Price · Currency is EUR 327.30
0.00 (0.00%)
Last updated: Jun 23, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
National Group Revenue (Post-FY2022) | 19.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
National Group Revenue (Post-FY2022) Growth | 8.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Atlantic Group Revenue (Post-FY2022) | 23.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Atlantic Group Revenue (Post-FY2022) Growth | 8.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
American Group Revenue (Post-FY2022) | 25.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
American Group Revenue (Post-FY2022) Growth | 8.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Revenue (Post-FY2022) | 3.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Revenue (Post-FY2022) Growth | -11.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
National Group Adjusted EBITDA (Post-FY2022) | 4.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
National Group Adjusted EBITDA (Post-FY2022) Growth | 15.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Atlantic Group Adjusted EBITDA (Post-FY2022) | 5.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Atlantic Group Adjusted EBITDA (Post-FY2022) Growth | 10.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
American Group Adjusted EBITDA (Post-FY2022) | 5.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
American Group Adjusted EBITDA (Post-FY2022) Growth | 8.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Adjusted EBITDA (Post-FY2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Adjusted EBITDA (Post-FY2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Number of Hospitals | 192.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Number of Hospitals Growth | 2.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Number of Freestanding Outpatient Surgery Centers | 125.00 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Number of Freestanding Outpatient Surgery Centers Growth | 3.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Number of Licensed Beds | 50.57K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Number of Licensed Beds Growth | 1.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Admissions | 2.25M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Admissions Growth | 2.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Average Length of Stay (days) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Average Length of Stay (days) Growth | -0.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Occupancy Rate | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Occupancy Rate Growth | 2.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|